As part of a growing trend of pharmaceutical giants reshoring their operations, AstraZeneca (AZN) announced Monday that it ...

DelveInsight’s, “Diabetes Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 200+ ...

AstraZeneca plans a $50 billion investment to expand its US manufacturing and research capacity by 2030, driven by tariff ...

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere ...

Astrazeneca has unveiled plans to invest as much as $50bn in manufacturing and R&D in the US after ditching its UK expansion ...

Astrazeneca said it will spend the huge sum over the next five years, including on a new manufacturing facility in Virginia, ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

The decline in the company's share price came as its shares traded ex-date following the announcement of a ₹32 per share ...

29 April 2025 EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical ...

AstraZeneca Vietnam has been honoured in the Outstanding CSR Activities category at the 2025 Top 50 Corporate Sustainability ...

Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story CMS targets hospitals with site-neutral drug ruleThe ...

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy ...